|
|
|
| | | | IOTA has a close working relationship with the Department of Medicinal Chemistry at the Free University of Amsterdam. | | | | Built on drug discovery expertise in the field of pharmacological targets such as the histamine, acetylcholine, chemokine and nuclear hormone receptors, and led by IOTA co-founder Dr Iwan de Esch, the VU Discovery team has extensive experience working in drug discovery projects alongside both international pharma and academic partners. |
|  |
| | | | VU Discovery Studies | | Histamine Receptors | Nicotinic AChR / AChBPs | | Kinases | Nuclear Hormone Receptors | | Chemokine Receptors | |
|  |
|
|
|
|
